RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Standard BioTools Stock

Standard BioTools ROCE 2024

Standard BioTools ROCE

-0.39

Ticker

LAB

ISIN

US34385P1084

WKN

A0RADJ

In 2024, Standard BioTools's return on capital employed (ROCE) was -0.39, a -23.61% increase from the -0.51 ROCE in the previous year.

Standard BioTools Aktienanalyse

What does Standard BioTools do?

Fluidigm Corp is a biotechnology company specializing in innovative devices and solutions for DNA sequencing. The company was founded in 1999 in San Francisco and is currently headquartered in South San Francisco. It developed the Microfluidic Technology-Sensor, which allows for handling tiny amounts of fluids in a small space. This technology has enabled researchers to analyze complex samples and collect data with high accuracy. The company operates in two main segments: Analytical Instruments and Sample Preparation. In the Analytical Instruments segment, Fluidigm offers various devices suitable for DNA sequencing, including the Juno, C1, and Biomark platforms. It also provides a wide range of consumables to facilitate sample preparation. The Sample Preparation segment offers products and services to prepare and process samples for analysis, including microfluidic technology chips and modules, single-cell sequencing systems, and products for next-generation sequencing. Fluidigm serves customers in various industries, such as genomics research, cancer research, and medical fields, with a strong presence in North America, Europe, and Asia. The company is known for its continuous investment in research and development, as well as its innovative technologies and patents. Overall, Fluidigm's Microfluidic technology platform allows researchers to collect data in a small space with high accuracy. With a diversified portfolio of products and services, the company is well-positioned to continue growing and expanding its market presence in the coming years. Standard BioTools ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Standard BioTools's Return on Capital Employed (ROCE)

Standard BioTools's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Standard BioTools's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Standard BioTools's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Standard BioTools’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Standard BioTools stock

What is the ROCE (Return on Capital Employed) of Standard BioTools this year?

The ROCE of Standard BioTools is -0.39 undefined this year.

How has the ROCE (Return on Capital Employed) of Standard BioTools developed compared to the previous year?

The ROCE of Standard BioTools has increased by -23.61% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Standard BioTools?

A high Return on Capital Employed (ROCE) indicates that Standard BioTools has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Standard BioTools?

A low ROCE (Return on Capital Employed) can indicate that Standard BioTools has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Standard BioTools impact the company?

An increase in the ROCE of Standard BioTools can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Standard BioTools affect the company?

A decrease in ROCE of Standard BioTools can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Standard BioTools?

Some factors that can affect Standard BioTools's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Standard BioTools so important for investors?

The ROCE of Standard BioTools is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Standard BioTools take to improve the ROCE?

To improve the ROCE, Standard BioTools can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Standard BioTools pay?

Over the past 12 months, Standard BioTools paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Standard BioTools is expected to pay a dividend of 0 USD.

What is the dividend yield of Standard BioTools?

The current dividend yield of Standard BioTools is .

When does Standard BioTools pay dividends?

Standard BioTools pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Standard BioTools?

Standard BioTools paid dividends every year for the past 0 years.

What is the dividend of Standard BioTools?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Standard BioTools located?

Standard BioTools is assigned to the 'Health' sector.

Wann musste ich die Aktien von Standard BioTools kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Standard BioTools from 8/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/11/2024.

When did Standard BioTools pay the last dividend?

The last dividend was paid out on 8/11/2024.

What was the dividend of Standard BioTools in the year 2023?

In the year 2023, Standard BioTools distributed 0 USD as dividends.

In which currency does Standard BioTools pay out the dividend?

The dividends of Standard BioTools are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Standard BioTools stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Standard BioTools

Our stock analysis for Standard BioTools Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Standard BioTools Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.